FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

25321811000001106: Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80537301000001110 Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80537401000001119 Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Is a Ranitidine 75mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has AMP Ranicalm 75mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start